Research and Policy Repository

Evidence-based SGLT2 inhibitor and GLP-1 receptor agonist use by race in the VA healthcare system

Abstract: Importance: Adoption of novel therapeutics often lags for Black versus non-Hispanic White patients. Seminal clinical trials established the cardiovascular efficacy of …

Physical Health Peer reviewed

Tobacco cessation prescription utilization rates among Veterans with cancer who smoke

Abstract: Tobacco use is the single most important modifiable risk factor in patients undergoing cancer treatment. The VHA offers evidence-based tobacco cessation treatment, with …

Physical Health Peer reviewed

Effect of a Veterans Health Administration mandate to case review patients with opioid prescriptions on mortality among patients with opioid use disorder: a secondary analysis of the STORM randomized control trial

Abstract: The Veterans Health Administration (VHA) implemented the Stratification Tool for Opioid Risk Mitigation (STORM) to reduce the risk of serious adverse events (SAE) among …

Mental Health Physical Health Peer reviewed

Opioid and Sedative misuse among Veterans Wounded in Combat

Abstract: Military veterans wounded in combat are a high-risk group for emotional and physical distress, which may be exacerbated by misuse of prescription opioids and sedatives. …

Mental Health Physical Health Well-Being Peer reviewed

Linkage of VA and State Prescription Drug Monitoring Program Data to Examine Concurrent Opioid and Sedative‐Hypnotic Prescriptions among Veterans

Abstract: To examine the prevalence of concurrent Veterans Health Administration (VA) and non‐VA prescriptions for opioids and sedative‐hypnotic medications among post‐9/11 …

Mental Health Physical Health Well-Being Peer reviewed